Perennial Allergic Rhinitis In Pediatric Subjects
NCT00257595 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2013-05-06
Summary
To assess the safety of long-term use of cetirizine dry syrup in children with perennial allergic rhinitis.
Conditions
- Rhinitis, Allergic, Perennial
Interventions
- DRUG
-
Cetirizine Dry Syrup
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 2 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
Countries
More Related Trials
-
Seasonal Allergic Rhinitis In Pediatric Subjects
NCT00107757 ·Status: COMPLETED ·Phase: PHASE3
-
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00108914 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis
NCT00639587 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis
NCT01651871 ·Status: COMPLETED ·Phase: PHASE2
-
Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
NCT06288334 ·Status: RECRUITING ·Phase: PHASE4
-
A Study in Subjects With Perennial Allergic Rhinitis
NCT00210015 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)
NCT02932774 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis
NCT06577077 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Seasonal Allergic Rhinitis and Driving Ability
NCT00223587 ·Status: TERMINATED ·Phase: PHASE4
-
Safety Study of Olopatadine Nasal Spray
NCT00578331 ·Status: COMPLETED ·Phase: PHASE3
-
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
NCT01241214 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.
NCT06272409 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
NCT00578929 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
NCT07091357 ·Status: RECRUITING ·Phase: PHASE2
-
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917 ·Status: RECRUITING ·Phase: NA
-
Validation of an Allergic Rhinitis Control Test in Teenagers
NCT02818153 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic Rhinitis
NCT00334698 ·Status: COMPLETED ·Phase: NA
-
Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)
NCT00757562 ·Status: COMPLETED ·Phase: PHASE3
-
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
NCT00225823 ·Status: COMPLETED ·Phase: PHASE3
-
Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis
NCT05708157 ·Status: UNKNOWN
-
A Novel Biologic Therapy for Perennial Allergic Rhinitis
NCT03360071 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
NCT01484119 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Bronchodilation Effects of Cetirizine
NCT01781507 ·Status: COMPLETED ·Phase: PHASE4
-
Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis
NCT01622231 ·Status: COMPLETED ·Phase: PHASE3